Is a CGM Better Than a Glucometer?

Ask this in a clinic and you will usually get a quick answer — the sensor is better — followed immediately by a price. Ask it at home, where the money is real, and it stops being straightforward. A single FreeStyle Libre sensor costs more for fourteen days than a good glucometer costs once, and it does not actually replace the glucometer. The useful answer is that a CGM and a glucometer are not competing at the same task, and working out which question you are trying to answer is what decides whether the sensor is worth buying.

They are not measuring the same thing

A glucometer measures glucose in a drop of your blood, at the moment you press the strip against it. A CGM measures glucose in the interstitial fluid between the cells just under your skin, and works backwards from that to an estimate of your blood glucose. That distinction sounds academic until it puts two different numbers on two screens. Because the sensor is reading a different fluid, Diabetes UK notes that its readings lag behind blood glucose by up to 15 minutes (opens in a new tab), and the gap is widest exactly when glucose is moving fastest — after a meal, during exercise, or while a low is coming on.

So a mismatch between your sensor and your meter is usually not a fault in either device. If you scan at 190 twenty minutes after eating and then prick at 230, both readings can be honest. The sensor is describing where your interstitial fluid has got to; the meter is describing where your blood is now.

Which one is more accurate?

Each is accurate on its own terms. Abbott reports an overall MARD of 9.2% for the FreeStyle Libre 2 (opens in a new tab) — meaning the average sensor reading sits about nine percent away from a laboratory reference. Home glucometers are held to a different kind of standard: ISO 15197:2013 (opens in a new tab) requires 95% of results to fall within ±15% of a laboratory value at readings of 100 mg/dL and above.

Those two numbers are not directly comparable — one is an average gap, the other a pass mark — and neither device is a laboratory. What matters in practice is the shape of what each gives you. A finger prick gives you one reading you can act on immediately. A sensor gives you a reading every minute at slightly looser accuracy. For treating a low right now, the single accurate point wins. For finding out what your usual dinner actually does to you, the thousand points win, and it is not close.

What the trial evidence shows

When researchers have compared the two head to head, the advantage of CGM is real but smaller than the marketing implies. A 2024 meta-analysis in the Journal of Clinical Endocrinology & Metabolism (opens in a new tab) pooled 14 randomised trials in type 2 diabetes and found that CGM lowered HbA1c by 0.32% more than finger-prick monitoring did. That is a genuine improvement — roughly what adding a medication might achieve — but it is not the transformation the price tag suggests.

The subgroup is more informative than the headline. In the three trials that looked only at people managed on oral tablets without insulin, the improvement was 0.26% and did not reach statistical significance. That lines up with what guidelines say rather than contradicting it: the ADA’s Standards of Care (opens in a new tab) recommend CGM for adults with diabetes on insulin therapy, while saying it may be considered for adults on other glucose-lowering medications. “May be considered” is doing real work in that sentence.

None of this means a sensor is wasted if you are on tablets. It means the sensor does not lower your blood sugar by itself. What lowers it is whatever you change after seeing the data — and a sensor that is worn, admired, and then not acted on is a very expensive fourteen days.

The cost question, plainly

This is where the comparison usually ends for households in Pakistan, so it is worth laying out rather than gesturing at.

For most people that arithmetic settles the practical question. Continuous CGM use is roughly ten times the cost of regular finger-prick monitoring, and a glucometer you can afford to keep using is worth considerably more than a sensor you can afford exactly once. If buying a sensor would mean cutting back on test strips afterwards, it is the wrong purchase.

A more useful way to frame the choice

The way a sensor tends to earn its price here is not as a replacement for the meter but as a periodic investigation. One sensor, worn for fourteen days, bought with a specific question in mind that finger pricks genuinely cannot answer: why the fasting reading is high whatever you do at dinner, what your ordinary Sunday lunch actually does over three hours, whether the late-afternoon heaviness is a low or just tiredness.

Used that way — once or twice a year, with a question written down before the sensor goes on — the CGM is a diagnostic tool with a defined job, and the glucometer stays the daily instrument. Fourteen days also happens to be the minimum stretch of data the international consensus panel considers enough to draw conclusions from, which is one sensor exactly.

There is one group for whom the calculation genuinely changes. If you use insulin — particularly if you have had lows you did not feel coming, or you live alone — the case for continuous wear is about safety rather than curiosity, and that is precisely the group guidelines recommend it for. A finger prick cannot catch a 3am drop that nobody was awake for. A sensor can, and can be set to wake you.

Whichever device you use, the log is what carries the meaning

A sensor gives you fourteen days; a meter gives you scattered points. Recording readings alongside meals, medicines and timing in Diatic is what turns either one into a pattern you can act on.

Start logging (opens Diatic on Google Play in a new tab)